Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.

[1]  Weihua Guo,et al.  Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma in situ , 2019, Journal of cancer research and therapeutics.

[2]  M. Mathieu,et al.  Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Bitencourt,et al.  Magnetic resonance imaging of the breast: role in the evaluation of ductal carcinoma in situ , 2019, Radiologia brasileira.

[4]  G. Marta,et al.  Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score! , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  R. S. de Azevedo Neto,et al.  Development of a Model to Predict Invasiveness in Ductal Carcinoma In Situ Diagnosed by Percutaneous Biopsy—Original Study and Critical Evaluation of the Literature , 2018, Clinical breast cancer.

[6]  Emily S. Reisenbichler,et al.  Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery. , 2018, Archives of pathology & laboratory medicine.

[7]  A. P. Benveniste,et al.  Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)? , 2017, European journal of radiology.

[8]  M. Reeves,et al.  Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance , 2017, JAMA surgery.

[9]  C. Mercado,et al.  Ductal Carcinoma In Situ: The Whole Truth. , 2017, AJR. American journal of roentgenology.

[10]  Lars J. Grimm,et al.  Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring , 2016, Annals of surgical oncology.

[11]  Jian-Rong Ding,et al.  Apparent diffusion coefficient value of diffusion-weighted imaging for differential diagnosis of ductal carcinoma in situ and infiltrating ductal carcinoma. , 2016, Journal of cancer research and therapeutics.

[12]  S. Pinder,et al.  Addressing overtreatment of screen detected DCIS; the LORIS trial. , 2015, European journal of cancer.

[13]  E. Rutgers,et al.  Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. , 2015, European journal of cancer.

[14]  Ah Young Park,et al.  Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer. , 2014, European journal of radiology.

[15]  B. Poirier,et al.  Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy. , 2014, Anticancer research.

[16]  Ying Lu,et al.  Features of Occult Invasion in Biopsy‐Proven DCIS at Breast MRI , 2013, The breast journal.

[17]  M. Golatta,et al.  Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. , 2013, Breast.

[18]  J. Wesseling,et al.  Is DCIS Breast Cancer, and How Do I Treat it? , 2013, Current Treatment Options in Oncology.

[19]  A. Luini,et al.  Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. , 2012, Breast.

[20]  W. Han,et al.  Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. , 2012, Breast.

[21]  S. Ciatto,et al.  Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. , 2011, Radiology.

[22]  S. Ciatto,et al.  Accuracy of a Preoperative Model for Predicting Invasive Breast Cancer in Women with Ductal Carcinoma-in-situ on Vacuum-Assisted Core Needle Biopsy , 2011, Annals of Surgical Oncology.

[23]  E. Kurniawan,et al.  Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. , 2010, Archives of surgery.

[24]  Mahmud Mossa-Basha,et al.  Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  C. Lehman.  Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. , 2010, Journal of the National Cancer Institute. Monographs.

[26]  P. Tan,et al.  Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ , 2010, Modern Pathology.

[27]  T. Yankeelov,et al.  NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[28]  Min-Ying Su,et al.  Significance of breast lesion descriptors in the ACR BI‐RADS MRI lexicon , 2009, Cancer.

[29]  Robyn L. Birdwell,et al.  Pure ductal carcinoma in situ: a range of MRI features. , 2008, AJR. American journal of roentgenology.

[30]  E. Ko,et al.  Breast MRI for Evaluating Patients with Metastatic Axillary Lymph Node and Initially Negative Mammography and Sonography , 2007, Korean journal of radiology.

[31]  J. Peterse,et al.  Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core‐needle biopsy , 2007, The British journal of surgery.

[32]  S. Ciatto,et al.  Underestimation of malignancy of breast core‐needle biopsy , 2007, Cancer.

[33]  N. Sneige,et al.  Predictors of invasion in patients with core‐needle biopsy‐diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ , 2006, Cancer.

[34]  R. Mansel,et al.  Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases , 2006, Breast Cancer Research and Treatment.

[35]  D. Visscher,et al.  Histologic and Radiographic Analysis of Ductal Carcinoma In Situ Diagnosed Using Stereotactic Incisional Core Breast Biopsy , 2002, Modern Pathology.

[36]  S. Goodman,et al.  Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices. , 2001, Radiology.

[37]  W. P. Evans,et al.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. , 2001, Radiology.

[38]  I. Ellis,et al.  Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. , 1999, European journal of cancer.

[39]  M. Yaffe,et al.  Improvement in DCIS Detection Rates by MRI Over Time in a High‐Risk Breast Screening Study , 2011, The breast journal.